Latest Breaking News On - Clal biotechnology industries - Page 4 : comparemela.com

Israel Biotech Fund closes $112m second fund

Israel Biotech Fund closes $112m second fund IBF focuses on investments in drug development and medical diagnostics companies in all stages. Israel Biotech Fund (IBF) has closed its $112 million second fund. The fund was founded by managing partners Dr. David Sidransky, Dr. Yuval Cabilly, and Ido Zairi. The main investors in the second fund include Harel Insurance Investments and Financial Services Ltd. (TASE: HARL), pharmaceutical giant Bristol Myers Squibb (BMS) and the CBG Capital private equity fund. IBF s second fund is larger than its first fund, which amounted to $70 million, and slightly larger than the amount that it set out to raise.

David sidranskyRoni mamlukSol barerYuval cabillyBristol myers squibbJeff kindlerBiond biologicsTehila ben mosheIdo zairiLisrael biotech fundClal biotechnology industries ltdTeva pharmaceutical industries ltdAyala pharmaceuticalsIsrael innovation authorityFinancial services ltdHarel insurance investments

Plus500 Ltd (LSE:PLUS) | RNS | Plus500 Ltd - Directorate Changes

Plus500 Ltd (LSE:PLUS) | RNS | Plus500 Ltd - Directorate Changes
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

H efaIsrael generalNew zealandUnited kingdomSouth africaBet shemeshCity ofCharles fairbairnRob gurnerTami gottliebPete lambieRachel mannDavid zruiaReg hoareHarvest capital markets ltdTamar petroleum

Plus500 announces board changes | 4 February 2021

4 February 2021 | 08:53am StockMarketWire.com - Contracts for Difference trading platform, Plus 500, has announced a series of changes to its board of directors. Sigalia Heifetz will be joining the Board as a non-executive director, with immediate effect. She will be appointed to the Remuneration Committee, Regulatory and Risk Committee and Disclosure Committee of the Board. Ms Heifetz holds non-executive directorships at a number of leading Israel-based corporations across a range of sectors and industries, including Nesher Israel Cement Enterprises Ltd, Clal Industries, Golf & Co, Maman, Tamar Petroleum and Clal Biotechnology Industries. Tami Gottlieb has been nominated for appointment as an external and non-executive director at an Extraordinary General Meeting, expected to held on 16 March 2021, notice of which will be sent out shortly.

Charles fairbairnTami gottliebTamar petroleumRisk committeeGolf coRemuneration committeeClal industriesClal biotechnology industriesNesher israel cement enterprises ltdDisclosure committee of the boardDisclosure committeeClal biotechnologyExtraordinary general meetingAnnual general meetingசார்லஸ் ஃபேர்‌பேர்ந்தமி காட்‌லீப்

Investegate |Plus500 Ltd Announcements | Plus500 Ltd: Directorate Changes

Directorate Changes Plus500, a leading technology platform for trading Contracts for Difference ( CFDs ) internationally, today announces several changes to the composition of the Board of Directors (the Board ). Appointment of Sigalia Heifetz as Non-Executive Director Sigalia Heifetz will be joining the Board as a Non-Executive Director, with immediate effect. She will be appointed to the Remuneration Committee, Regulatory and Risk Committee and Disclosure Committee of the Board. Sigalia holds Non-Executive Directorships at a number of leading Israel-based corporations across a range of sectors and industries, including Nesher Israel Cement Enterprises Ltd, Clal Industries, Golf & Co, Maman, Tamar Petroleum and Clal Biotechnology Industries. She also previously held Non-Executive positions at Bet Shemesh Engines Ltd and Hadera Paper, prior to which she was an audit partner at accountancy firm BDO.

H efaIsrael generalNew zealandUnited kingdomSouth africaBet shemeshCity ofCharles fairbairnRob gurnerTami gottliebPete lambieRachel mannDavid zruiaReg hoareHarvest capital markets ltdTamar petroleum

Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Plus500 announces board changes

Contracts for Difference trading platform, Plus 500, has announced a series of changes to its board of directors. Sigalia Heifetz will be joining the Board as a non-executive director, with immediate effect. She will be appointed to the Remuneration Committee, Regulatory and Risk Committee and Disclosure Committee of the Board. Ms Heifetz holds non-executive directorships at a number of leading Israel-based corporations across a range of sectors and industries, including Nesher Israel Cement Enterprises Ltd, Clal Industries, Golf & Co, Maman, Tamar Petroleum and Clal Biotechnology Industries. Tami Gottlieb has been nominated for appointment as an external and non-executive director at an Extraordinary General Meeting, expected to held on 16 March 2021, notice of which will be sent out shortly.

Charles fairbairnTami gottliebTamar petroleumRisk committeeGolf coRemuneration committeeClal industriesClal biotechnology industriesNesher israel cement enterprises ltdDisclosure committee of the boardDisclosure committeeClal biotechnologyExtraordinary general meetingAnnual general meetingசார்லஸ் ஃபேர்‌பேர்ந்தமி காட்‌லீப்